Effect of the CE on IL-1 Immunostaining of the pro-inflammatory cytokine IL-1 (a marker of pyroptosis) in the brain tissue was performed
Science 347 , 13741377 (2015)
The most common MCAS symptoms are: Systemic fatigue, sensitivity to food and medication Respiratory nasal congestion, shortness of breath, asthma, throat swelling Neurological headaches, migraines Mental/emotional decreased concentration, memory
Tirzepatide is a dual GIP/GLP-1 receptor agonist that produces mean body weight reductions of 20.9% at 72 weeks by delaying gastric emptying, suppressing ghrelin rebound, and enhancing glucose-dependent insulin secretion
Therefore, future studies should attempt to incorporate novel biomarkers into a panel that includes nAchR and SMCT for neonicotinoid exposure
Understanding potential adverse effects enables informed decision-making and appropriate medical monitoring